{"Q": 1, "answer": "no", "rationale": "The segment reports discussions but does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19400", "batch_size": 200, "batch_pos": 128, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports discussions factually, lacking high-potency language.", "method": "llm_batch", "batch_id": "batch_2_13400", "batch_size": 200, "batch_pos": 112, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with significant scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_13044", "batch_size": 200, "batch_pos": 88, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14484", "batch_size": 200, "batch_pos": 86, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "Reports discussions; lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_1932", "batch_size": 200, "batch_pos": 82, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_14860", "batch_size": 200, "batch_pos": 66, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment reports discussions with the government and does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_6524", "batch_size": 200, "batch_pos": 63, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes ongoing discussions/effort ('are in discussions... on advancing') which is a capability/effort, without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_17008", "batch_size": 200, "batch_pos": 187, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
